References
- Notice #2014-46, KMFDS 'Korean Pharmacopoeia: General Formulation' http://www. mfds.go.kr/index.do?x=0&searchkey =title:contents&mid=1013&searchword=대한민국약전&y= 0&division=&pageNo=1&seq=6313&cmd=v (Accessed on February 12, 2014).
- Transdermal formulation, Choi HK, Shinil Books, Seoul, Korea, 1999.
- Report information by Korea Customer Agency http:// www.kca.go.kr/brd/m_32/view.do?seq=1361&multi_itm_seq=, (Accessed on November 9, 2012).
- Korea National Institute of Food and Drug Safety Evaluation, "Research on establishing of guidelines for evaluating the effectiveness of drug safety", 2011.
-
Japanese Pharmacopoeia
$15^{th}$ edition, Ministry of Health, 2010. -
United States Pharmacopoeia
$34^{th}$ edition, USP Convention, 2011. - European Pharmacopoeia 7.0, European Directorate for the Quality of Medicines & Health Care, 2011.
- EZdrug, Korea Ministry of Food and Drug Safety. http:// ezdrug.mfds.go.kr (Accessed on June, 2014)
- Notice #2014-46, KMFDS 'Korean Pharmacopoeia: Individual Monograph'. Internet site: http://www.mfds.go.kr/ index.do?x=0&searchkey=title:contents&mid=1013&searchwo rd= 대한민국약전&y=0&division=&pageNo=1&seq=6313 &cmd=v (Accessed on February 12, 2014).
- Notice #2013-235, KMFD 'Criteria for non-formulary drugs excluding Korean Pharmacopoeia'. Internet site: http://www. mfds.go.kr/index.do?x=0&searchkey= title:contents&mid =1013&searchword=대한민국약전외&y= 0&division=&page No=1&seq=6312&cmd=v (Accessed on November 21, 2013).
- Notice #2014-58, KMFD 'Regulations for marketing and sales, report, review of authorized medications'. Internet site: http://www.mfds.go.kr/index.do?x=0&searchkey=title: contents&mid=1013&searchword= 의약품의 품목&y=0& division=&pageNo=1&seq=7773&cmd=v (Accessed on February 12, 2014).
- Notice #2014-77, KMFD 'Standards and test methods on the quasi-drugs'. Internet site: http://www.mfds.go.kr/ index.do?x=0&searchkey=title:contents&mid=1013&search word= 의약외품 &y=0&division=&pageNo=1&seq=7737 &cmd=v (Accessed on February 12, 2014).
- Drug approval and licensing procedures in Japan 2010.
- Prez-Caldern R, Gonzalo-Garijo MA, Rodrguez-Nevado I. Generalized allergic contact dermatitis from nitroglycerin in transdermal therapeutic system. Contact Dermatitis 2002;46(5):303. https://doi.org/10.1034/j.1600-0536.2002.460513.x
- Alfaya T, Mur Gimeno P, Iglesias AM, et al. Allergic contact dermatitis caused by an ethinylestradiolnorelgestromin transdermal therapeutic system. Contact Dermatitis 2011;64(4):237-44. https://doi.org/10.1111/j.1600-0536.2010.01848.x
- FDA safety page, drug topics. April 1, 2002. Lee M and Phillips J.
- Tokumura F, Ohyama K, Fujisawa H, et al. Conformability and irritancy of adhesive tapes on the skin. Contact Dermatitis 1997;37(4):173-78. https://doi.org/10.1111/j.1600-0536.1997.tb00191.x
- Wokovich AM, Prodduturi S, Doub WH, et al. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute. Eur J Pharm Biopharm 2006;64(1):1-8. https://doi.org/10.1016/j.ejpb.2006.03.009
- Cilurzo F, Gennari CG, Minghetti P. Adhesive properties: a critical issue in trans- dermal patch development. Expert opin drug deliv 2012;9(1):33-45. https://doi.org/10.1517/17425247.2012.637107
- Satas D. Handbook of Pressure Sensitive Adhesive Technology, 3rd ed. Rhode Island: Satas & Associates, 1999;36-61.
- Korea Pharmaceutical Information Center (Accessible at http://www.health.kr)
- Druginfo, Drug Information Organization in Korea (Accessible at http://www.druginfo.co.kr)